Cargando…

Hepatitis B and C Co-Infection Are Independent Predictors of Progressive Kidney Disease in HIV-Positive, Antiretroviral-Treated Adults

Chronic kidney disease (CKD) is an important cause of morbidity and mortality in HIV-positive individuals. Hepatitis C (HCV) co-infection has been associated with increased risk of CKD, but prior studies lack information on potential mechanisms. We evaluated the association between HCV or hepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mocroft, Amanda, Neuhaus, Jacqueline, Peters, Lars, Ryom, Lene, Bickel, Markus, Grint, Daniel, Koirala, Janak, Szymczak, Aleksandra, Lundgren, Jens, Ross, Michael J., Wyatt, Christina M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3401192/ https://www.ncbi.nlm.nih.gov/pubmed/22911697 http://dx.doi.org/10.1371/journal.pone.0040245

Ejemplares similares

HIV and hepatitis C co-infection in Europe, Israel and Argentina: a EuroSIDA perspective
por: Peters, Lars, et al.
Publicado: (2014)

Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study
por: Mocroft, Amanda, et al.
Publicado: (2015)

The prevalence and predictive value of dipstick urine protein in HIV-positive persons in Europe
por: Mocroft, Amanda, et al.
Publicado: (2014)

Lack of association between use of efavirenz and death from suicide: evidence from the D:A:D study
por: Smith, Colette, et al.
Publicado: (2014)

Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study
por: Kamara, David A, et al.
Publicado: (2014)

A clinically useful risk-score for chronic kidney disease in HIV infection
por: Mocroft, Amanda, et al.
Publicado: (2014)

Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study()
por: Hatleberg, Camilla Ingrid, et al.
Publicado: (2019)

Ritonavir-Boosted Protease Inhibitors Do Not Significantly Affect the Performance of Creatinine-Based Estimates of GFR
por: Wyatt, Christina M., et al.
Publicado: (2020)

Gender differences in HIV-positive persons in use of cardiovascular disease-related interventions: D:A:D study
por: Hatleberg, Camilla Ingrid, et al.
Publicado: (2014)

1075. Absolute Lymphocyte Count as a Predictor of Cytomegalovirus (CMV) Infection and Recurrence in Hematopoietic Stem Cell Transplant (HSCT) Recipients
por: Reekie, Joanne, et al.
Publicado: (2020)

Gender differences in the use of cardiovascular interventions in HIV‐positive persons; the D:A:D Study
por: Hatleberg, Camilla I, et al.
Publicado: (2018)

Temporal changes and regional differences in treatment uptake of hepatitis C therapy in EuroSIDA*
por: Grint, D, et al.
Publicado: (2013)

Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients
por: Peters, Lars, et al.
Publicado: (2013)

Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration
por: Sabin, Caroline A., et al.
Publicado: (2016)

Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study
por: Boyd, Mark A., et al.
Publicado: (2017)

Trends in Cancer Incidence in Different Antiretroviral Treatment-Eras amongst People with HIV
por: Greenberg, Lauren, et al.
Publicado: (2023)

Changing antiretrovirals whilst viral load <50 copies/ml and relationship with CD4 count changes
por: Mocroft, A
Publicado: (2010)

Chronic kidney disease in patients with normal eGFR at baseline: results from EuroSIDA
por: Ryom, L, et al.
Publicado: (2010)

Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study
por: Kovari, Helen, et al.
Publicado: (2016)

Association of Suboptimal Antiretroviral Therapy Adherence With Inflammation in Virologically Suppressed Individuals Enrolled in the SMART Study
por: Castillo-Mancilla, Jose R, et al.
Publicado: (2017)

A comparison of estimated glomerular filtration rates using Cockcroft−Gault and the Chronic Kidney Disease Epidemiology Collaboration estimating equations in HIV infection
por: Mocroft, A, et al.
Publicado: (2014)

Persistent disparities in antiretroviral treatment (ART) coverage and virological suppression across Europe, 2004 to 2015
por: Laut, Kamilla, et al.
Publicado: (2018)

Prediction of Febrile Neutropenia after Chemotherapy Based on Pretreatment Risk Factors among Cancer Patients
por: Aagaard, Theis, et al.
Publicado: (2017)

Nepal Earthquake: An Experience from Ground Zero
por: Koirala, Janak, et al.
Publicado: (2019)

COVID-19 Containment Efforts of a Low-Resource Nation: The First Four Months in Nepal
por: Basnet, Sangita, et al.
Publicado: (2020)

Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium
por: Byonanebye, Dathan M., et al.
Publicado: (2022)

Predictive value of prostate-specific antigen for prostate cancer: a nested case-control study in EuroSIDA
por: Shepherd, Leah, et al.
Publicado: (2014)

Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States
por: Boettiger, David C, et al.
Publicado: (2021)

1549. Development and Validation of a Cycle-Specific Risk Score for Febrile Neutropenia After Chemotherapy in Patients with Cancer: The (CSR)FENCE Score
por: Aagaard, Theis, et al.
Publicado: (2018)

Haemoglobin and anaemia in the SMART study
por: Mocroft, A, et al.
Publicado: (2010)

Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients
por: Khurana, Mark P, et al.
Publicado: (2019)

1597. Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus (CMV) Infection and Disease in Solid Organ Transplant (SOT) Recipients
por: Khurana, Mark Poulsen, et al.
Publicado: (2018)

2613. The Epidemiology of Respiratory Syncytial Virus (RSV) in People with Immune Dysfunction Seen at a Tertiary Hospital Between 2010 and 2017
por: Li, Qiuju, et al.
Publicado: (2019)

Corynebacterium CDC Group G Native and Prosthetic Valve Endocarditis
por: Sattar, Adil, et al.
Publicado: (2015)

Impact of Insurance and Treatment Regimens on HCV Outcome: Long-term Follow-up Study
por: Mukka, Mallikarjuna, et al.
Publicado: (2017)

Mortality and admission to intensive care units after febrile neutropenia in patients with cancer
por: Aagaard, Theis, et al.
Publicado: (2020)

TB Meningitis in HIV-Positive Patients in Europe and Argentina: Clinical Outcome and Factors Associated with Mortality
por: Efsen, Anne Marie W., et al.
Publicado: (2013)

The Presence of CXCR4-Using HIV-1 Prior to Start of Antiretroviral Therapy Is an Independent Predictor of Delayed Viral Suppression
por: Gijsbers, Esther F., et al.
Publicado: (2013)

Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial
por: Dharan, Nila J., et al.
Publicado: (2019)

Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America
por: Caro-Vega, Yanink, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_91m1lianlnf1ekjv9mj6re65sh